Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP000854

Drug Information
SynonymsIDI1_002118; KBio2_007405; Bio-E-Gel; Prestwick3_000441; BIDD:PXR0065; 3,17-beta-Oestradiol; estradiol; HMS1990E07; Progynon DH; HSDB 3589; Dihydroxyestrin; CID5757; Sandrena 1; Estrasorb; nchembio794-comp6; KBio3_000769; 17.beta.-Oestradiol; Macrodiol; KBio2_005541; Oestradiol-17.beta.; E 8875; MolPort-001-794-632; D-Estradiol; 3,17.beta.-Estradiol; 17-beta; Estraderm TTS 100; Ginosedol; component of Menrium; 17-E; D00105; [2,4,6,7-3H]-E2; NSC-9895; Femtran; Estrogel; Sandrena Gel; Polyestradiol; KBio2_002973; Estrofem Forte; [3H]-estradiol; Femanest; Oestrogynal; Macrol; Evamist; SMR000059126; cis-Oestradiol; Bio1_000403; KBio2_004837; Estradiolum; 73459-61-7; Oesclim; Estring; SL-1100; NCGC00091544-07; Gynoestryl; Divigel (TN); 17-beta-estradiol; Tradelia; CHEBI:16469; B-Estradiol; Sisare Gel; S-21400; BPBio1_000532; Femestral; Aerodiol; Profoliol; EINECS 200-023-8; VIVELLE-DOT; Menest; NCGC00091544-05; Lopac0_000503; Climaderm; Microdiol; NCGC00091544-09; SAM001247032; Bardiol; Estradiol-17-beta; 17beta oestradiol; Estring (TN); Evorel; bmse000642; Femogen; Estraderm TTS 50; CPD-352; Dihydroxyoestrin; cMAP_000005; D-3,17beta-Estradiol; Ovociclina; Femtrace; Vagifem; 2d06; Nordicol; Prestwick0_000441; Oestergon; progynon; Estroclim; Estrifam; Aquadiol; Zesteen; Perlatanol; Esclim; 17.beta.-Estradiol; KBioGR_000405; NCGC00091544-04; Climara Forte; Bio1_000892; E0025; HMS2090E18; Dimenformon; BSPBio_001065; Estraderm; SMP1_000121; Oestradiol-17-beta; Oestradiol R; SPBio_002421; BSPBio_000482; Gelestra; Estrodiolum; estradiol-17beta; Destradiol; Ovocylin; Follicyclin; Systen; Dihydromenformon; Estraldine; NCGC00091544-08; Zerella; Dermestril; cis-Estradiol; NCGC00091544-02; CMC_11154; E(sub 2); Estrace; KBio2_002269; Estradiolo [DCIT]; Climara; MLS000758312; NCGC00091544-12; S1709_Selleck; AC1L1L2K; Theelin, dihydro-; Dihydrotheelin; Gynodiol; KBio2_000405; Estraderm (TN); LMST02010001; HMS2051C17; HMS1792E07; GynPolar; Encore; nchembio775-comp2; Estradiolo; MLS000069494; 873662-39-6; Fempatch; Alora; Oestrogel; Altrad; Estraderm TTS; KBioSS_002270; Zesteem; nchembio.76-comp2; SK-Estrogens; 1jgl; Femestrol; NCGC00179321-02; E2758_SIGMA; 17beta-Oestradiol; Climara (TN); Oestradiol-17beta; Vivelle (TN); 50-28-2; nchembio860-comp1; Compudose 365; Estradot; MLS001076331; Diogynets; C18H24O2; Progynon-DH; Corpagen; E8875_SIGMA; HMS1569I04; Estradiol-17.beta.; Zumenon; nchembio.168-comp3; Estrofem 2; Estreva; Spectrum5_002055; .beta.-Estradiol; 17-.BETA.-Estradiol; EU-0100503; D-Oestradiol; Trial SAT; KBioGR_002269; KBioSS_000405; Innofem; NCGC00179321-01; 17 beta-Estradiol; E2257_SIGMA; Prestwick2_000441; 3,17-beta-Estradiol; CPD000059126; Estrovite; Syndiol; Estrace (TN); Trocosone; Vivelle; Diogyn; UNII-4TI98Z838E; Estrapak 50; Ovocyclin; NSC9895; Compudose 200; CHEMBL135; Estradiol, .beta.-; Epiestriol 50; Bio2_000363; Estroclim 50; KBio3_002749; Elestrin; .beta.-Oestradiol; KBio3_000770; NCGC00091544-06; E 2; Ovasterol; Ovocycline; LS-137; Gynestrel; Bio-0812; Ginedisc; HMS1362E07; C00951; Oestradiol; 1qkt; Lamdiol; Bio1_001381; .alpha.-Estradiol; Innofem (TN); Extrasorb; Vagifem (TN); Oestroglandol; NCGC00091544-01; Estradiolum [INN]; Ovastevol; Beta-estradiol; 17beta-Estradiol; 17b-Oestradiol; Profoliol B; Ovahormon; Estrogel (TN); 17E; E1024_SIGMA; E1132_SIGMA; Oestradiolum; BIDD:ER0125; Prestwick1_000441; Oestradiol Berco; Primofol; [3H]]estradiol; Compudose; Bio2_000843; 3,17beta-Estradiol; Estradiol-3,17beta; DB00783; Menorest; 17beta-Estradiol; Estring vaginal ring; .alpha.-Oestradiol; Estradiol [USAN:INN]; Dihydroxyesterin; AC-10460; Divigel; 17-beta-OH-estradiol; Estradiol-17 beta; Gynergon; NCGC00091544-00; Estrasorb (TN); Prestwick_207; Estraderm MX; CCRIS 280; Dihydrofolliculin; 1qku; beta-Estradiol    
Trade NameEstrace; Estradiol acetate; Estrofem; Alora; Climara; Vivelle-Dot; Menostar; Estraderm TTS; EvaMist; Divigel; Estrasorb Topical; Estrogel; Elestrin; Estradiol cypionate; Estradiol valerate; Estrace; Estring; Femring; Activella; AngeliQ; Progynova    
IndicationHormone replacement therapyApproved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Therapeutic ClassEstrogens    
CAS NumberCAS 50-28-2
PubChem Compound IDCID 5757.    
PubChem Substance IDSID 2384.    
SuperDrug ATC IDG03CA03;    
SuperDrug CAS ID000050282;    
TargetEstrogen receptorAgonist[2]
Ref 1Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. Epub 2007 Feb 20. To Reference
Ref 2Reprint of Are all estrogens the same? Maturitas. 2008 Sep-Oct;61(1-2):195-201. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543